NYSE: MRK
Merck & Co Inc Stock

Overview

Forecast Earnings Dividend Ownership

MRK Price

$83.03

Fair Value Price

N/A

Market Cap

$210.00B

52 Week Low

$65.25

52 Week High

$92.06

P/E

18.25x

P/B

7.2x

P/S

4.43x

PEG

1.56x

Dividend Yield

2.94%

Revenue

$47.35B

Earnings

$11.52B

Gross Margin

71.2%

Operating Margin

28.63%

Profit Margin

24.3%

Debt to Equity

2.07

Operating Cash Flow

$11B

Beta

0.7

Next Earnings

Feb 4, 2021

Ex-Dividend

N/A

Next Dividend

N/A

Zen Score

Expand Score

High

Medium

Low

Industry average

Reasons for this score

MRK ($83.03) is trading below its intrinsic value of $253.20, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"

Valuation

MRK is good value based on its earnings relative to its share price (18.25x), compared to the US market average 40.05x)

Valuation

MRK is good value based on its earnings relative to its share price (18.25x), compared to the US Drug Manufacturers - General industry average (-4.33x)

Valuation

MRK News

Valuation

MRK price to earnings (PE)

For valuing profitable companies with steady earnings

Company

18.25x

Industry

-4.33x

Market

40.05x

MRK is good value based on its earnings relative to its share price (18.25x), compared to the US market average 40.05x)

Valuation

MRK is good value based on its earnings relative to its share price (18.25x), compared to the US Drug Manufacturers - General industry average (-4.33x)

Valuation

MRK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company

7.2x

Industry

8.46x

Market

36.62x

MRK is good value based on its book value relative to its share price (7.2x), compared to the US market average (36.62x)

Valuation

MRK is good value based on its book value relative to its share price (7.2x), compared to the US Drug Manufacturers - General industry average (8.46x)

Valuation

MRK price to earnings growth (PEG)

For valuing profitable companies with growth potential

MRK is poor value relative to its rate of earnings growth, measured by PEG ratio (1.56x)

Valuation

MRK's financial health

Profit margin

Revenue

$12.6B

Net Income

$2.9B

Profit Margin

23.4%

MRK's Earnings (EBIT) of $13.56B can safely cover interest payments on company debt ($28.74B)

Financials

MRK's profit margin has increased (+4%) in the last year from (20.3%) to (24.3%)

Financials

Assets to liabilities

Assets

$89.8B

Liabilities

$60.5B

Debt to equity

0.98

MRK's short-term assets ($26.58B) exceed its short-term liabilities ($20.41B)

Financials

MRK's long-term liabilities ($40.13B) exceed its short-term assets ($26.58B)

Financials

MRK's debt has increased relative to shareholder equity (2.07), over the past 5 years ago (1.22)

Financials

MRK's debt to equity ratio (2.07) is considered high

Financials

Cash flow

Operating

$2.2B

Investing

-$2.2B

Financing

-$3.9B

MRK's operating cash flow ($11.04B) is sufficient to service the company's debt ($28.74B)

Financials

Merck & Stock FAQ

What is Merck &'s quote symbol?

(NYSE: MRK) Merck & trades on the NYSE under the ticker symbol MRK. Merck & stock quotes can also be displayed as NYSE: MRK.

How much is Merck &'s stock price per share?

(NYSE: MRK) Merck & stock price per share is $83.03 today (as of Jan 8, 2021).

What is the 52 week high and low for Merck & (NYSE: MRK)?

(NYSE: MRK) Merck &'s 52-week high was $92.06, and its 52-week low was $65.25. It is currently -9.8% from its 52-week high and 27.25% from its 52-week low.

What is Merck &'s Market Cap?

(NYSE: MRK) Merck &'s market cap is $210.00B, as of Jan 16, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Merck &'s market cap is calculated by multiplying MRK's current stock price of $83.03 by MRK's total outstanding shares of 2,529,241,070.

How much is Merck & stock worth today?

(NYSE: MRK) Merck & currently has 2,529,241,070 outstanding shares. With Merck & stock trading at $83.03 per share, the total value of Merck & stock (market capitalization) is $210.00B.

Merck & stock was originally listed at a price of $53.00 in Dec 31, 1997. If you had invested in Merck & stock at $53.00, your return over the last 23 years would have been 56.66%, for an annualized return of 1.97%.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Zen Score

Reasons for this score

MRK News

Valuation

MRK price to earnings (PE)

For valuing profitable companies with steady earnings

MRK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

MRK price to earnings growth (PEG)

For valuing profitable companies with growth potential

MRK's financial health

Profit margin

Assets to liabilities

Cash flow

Merck & Stock FAQ

(NYSE: MRK) Merck & trades on the NYSE under the ticker symbol MRK. Merck & stock quotes can also be displayed as NYSE: MRK.

(NYSE: MRK) Merck & stock price per share is $83.03 today (as of Jan 8, 2021).

(NYSE: MRK) Merck &'s 52-week high was $92.06, and its 52-week low was $65.25. It is currently -9.8% from its 52-week high and 27.25% from its 52-week low.

Company

Stocks

Social